The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials.
Publication
, Journal Article
Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria,
Published in: Arthritis Rheum
February 2006
Duke Scholars
Published In
Arthritis Rheum
DOI
ISSN
0004-3591
Publication Date
February 2006
Volume
54
Issue
2
Start / End Page
421 / 432
Location
United States
Related Subject Headings
- Treatment Outcome
- Societies, Medical
- Rheumatology
- MEDLINE
- Lupus Nephritis
- Humans
- Endpoint Determination
- Clinical Trials as Topic
- Arthritis & Rheumatology
- Americas
Citation
APA
Chicago
ICMJE
MLA
NLM
Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria, . (2006). The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum, 54(2), 421–432. https://doi.org/10.1002/art.21625
Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria, Richard. “The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials.” Arthritis Rheum 54, no. 2 (February 2006): 421–32. https://doi.org/10.1002/art.21625.
Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum. 2006 Feb;54(2):421–32.
Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria, Richard. “The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials.” Arthritis Rheum, vol. 54, no. 2, Feb. 2006, pp. 421–32. Pubmed, doi:10.1002/art.21625.
Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum. 2006 Feb;54(2):421–432.
Published In
Arthritis Rheum
DOI
ISSN
0004-3591
Publication Date
February 2006
Volume
54
Issue
2
Start / End Page
421 / 432
Location
United States
Related Subject Headings
- Treatment Outcome
- Societies, Medical
- Rheumatology
- MEDLINE
- Lupus Nephritis
- Humans
- Endpoint Determination
- Clinical Trials as Topic
- Arthritis & Rheumatology
- Americas